KINETICS OF COTININE AFTER ORAL AND INTRAVENOUS ADMINISTRATION TO MAN

被引：49

作者：

DESCHEPPER, PJ

VANHECKEN, A

DAENENS, P

VANROSSUM, JM

机构：

[1] CATHOLIC UNIV LEUVEN,DEPT TOXIKOL,B-3000 LOUVAIN,BELGIUM

[2] CATHOLIC UNIV NIJMEGEN,DEPT PHARMACOL,NIJMEGEN,NETHERLANDS

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1987年 / 31卷 / 05期

关键词：

D O I：

10.1007/BF00606635

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：583 / 588

页数：6

共 22 条

[1] COTININE DISPOSITION AND EFFECTS [J].

BENOWITZ, NL ;

KUYT, F ;

JACOB, P ;

JONES, RT ;

OSMAN, AL .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (05) :604-611

[2] SMOKERS OF LOW-YIELD CIGARETTES DO NOT CONSUME LESS NICOTINE [J].

BENOWITZ, NL ;

HALL, SM ;

HERNING, RI ;

JACOB, P ;

JONES, RT ;

OSMAN, AL .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (03) :139-142

[3]

BOWMAN ER, 1959, J PHARMACOL EXP THER, V127, P92

[4] DETERMINATION OF COTININE IN BIOLOGICAL-FLUIDS BY CAPILLARY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY - SELECTED-ION MONITORING [J].

DAENENS, P ;

LARUELLE, L ;

CALLEWAERT, K ;

DESCHEPPER, P ;

GALEAZZI, R ;

VANROSSUM, J .

JOURNAL OF CHROMATOGRAPHY, 1985, 342 (01) :79-87

[5] CIGARETTE-SMOKING PHARMACOKINETICS AND ITS RELATIONSHIP TO SMOKING-BEHAVIOR [J].

DARBY, TD ;

MCNAMEE, JE ;

VANROSSUM, JM .

CLINICAL PHARMACOKINETICS, 1984, 9 (05) :435-449

[6] STEADY-STATE CONCENTRATION OF COTININE AS A MEASURE OF NICOTINE-INTAKE BY SMOKERS [J].

GALEAZZI, RL ;

DAENENS, P ;

GUGGER, M .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (03) :301-304

[7]

GIBALDI M, 1982, PHARMACOKINETICS

[8]

Gori G B, 1983, Regul Toxicol Pharmacol, V3, P110, DOI 10.1016/0273-2300(83)90035-1

[9] MEASURING THE EXPOSURE OF INFANTS TO TOBACCO-SMOKE - NICOTINE AND COTININE IN URINE AND SALIVA [J].

GREENBERG, RA ;

HALEY, NJ ;

ETZEL, RA ;

LODA, FA .

NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (17) :1075-1078

[10] PLASMA NICOTINE AND COTININE CONCENTRATIONS IN HABITUAL SMOKELESS TOBACCO USERS [J].

GRITZ, ER ;

BAERWEISS, V ;

BENOWITZ, NL ;

VANVUNAKIS, H ;

JARVIK, ME .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :201-209

← 1 2 3 →